Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
News

UK approves Prima BioMed to initiate Phase II b trial of IMP321 to treat metastatic breast cancer

Go Top